| Dr Jean-Pierre Bru No or few national guidelines for pneumonia (PNA), urinary tract infection (UTI), and acute bacterial skin and skin structure infection … Suite
| Dr Jean-Pierre Bru Dual therapy with vancomycin (oral/nasogastric tube/rectal instillation) and intravenous (IV) metronidazole is recommended only for the treatment of severe CDI … Suite
| Dr Jean-Pierre Bru Lefamulin is a pleuromutilin antibiotic. Its name comes from the pleuromutilin-producing fungus Pleurotus mutilus. Previous pleuromutilin are already used : … Suite
| Dr Philippe Lesprit Vancomycin is the first-line treatment of glycopeptide (GP)-susceptible E. faecium (GSEF)-bloodstream infections (BSI) except for the rare amoxicillin-sensitive strains. GP … Suite
| Dr Olivier Leroy Although S. maltophilia is regularly identified as the causal agent of nosocomial pneumonia, the optimal modalities of antimicrobial therapy remain … Suite
| Dr Jean-Pierre Bru Colistin is one of a limited number of options for the treatment of carbapenem-resistant Gram-negative bacteria. A previously published randomized … Suite
| Dr Olivier Leroy There is mounting evidence that delays in appropriate antimicrobial administration are responsible for preventable deaths in patients with sepsis. The … Suite
| Dr Philippe Lesprit A randomized controlled trial including 604 patients with gram-negative bloodstream infections (BSI) – including both Enterobacteriaceae and glucose non-fermenting gram-negative … Suite
| Dr Philippe Lesprit Viral respiratory infections are a common cause of antibiotic prescribing, including in hospitals. Tools such as procalcitonin assay (PCT) or … Suite
| Dr Jean-Pierre Bru Synergy between third-generation cephalosporins (TGCs) and ampicillin was discovered in 1995 by Mainardi et al. and then confirmed in many … Suite
